Get the Stockscreener App
4.58
6.02%
0.26
Nevro Corp Stock (NVRO) Latest News
Nevro Corp. (NYSE:NVRO) Receives Average Recommendation of "Reduce" from Brokerages - MarketBeat
Nevro Stock Rises on Q3 Earnings Beat, Revenues Decrease Y/Y - MSN
Nevro’s HFX iQ™ Spinal Cord Technology Receives CE Mark Certification in Europe - TechRound
NVRO Stock Declines Despite Positive Study Data of Nevro1 System - MSN
Nevro Stock May Gain on the CE Mark Certification for HFX iQ - MSN
Nevro secures CE mark for AI-based spinal cord stimulation system - MSN
Nevro’s SI joint fixation system delivers enhanced stability and fusion for patients - Mass Device
Nevro announces publication of new data on Nevro1 SI Joint Fusion System - TipRanks
New Study Demonstrates Multiple Advantages of Nevro1™ | Trending From Our Network - Chicago Star Media
Nevro Corp announces inducement grants - Medical Buyer
Nevro Announces New Employee Inducement Grants Under NYSE Rule 303A.08 - Quantisnow
Engaged Capital LLC Adjusts Its Stake in Nevro Corp - GuruFocus.com
ARMISTICE CAPITAL, LLC Acquires Additional Shares in Nevro Corp - GuruFocus.com
Amendment: SEC Form SC 13D/A filed by Nevro Corp. - Quantisnow
Nevro Corp. Reports Strong Q3 2024 Financial Performance - TipRanks
Nevro Corp. (NVRO) Quarterly 10-Q Report - Quartzy
NVRO stock touches 52-week low at $4.35 amid market challenges - Investing.com
FY2024 Earnings Forecast for Nevro Issued By William Blair - MarketBeat
Nevro Corp.'s SWOT analysis: stock faces headwinds amid market challenges - Investing.com Australia
Analysts Are Updating Their Nevro Corp. (NYSE:NVRO) Estimates After Its Third-Quarter Results - Yahoo Finance
Nevro wins CE mark for spinal cord stimulation technology - BioWorld Online
FY2026 Earnings Estimate for Nevro Issued By William Blair - MarketBeat
Nevro stock price target cut, retains hold rating on earnings release - Investing.com Canada
Nevro Third Quarter 2024 Earnings: Beats Expectations - Yahoo Finance
Nevro Corp’s Market Cap Challenges: Impairment Risks and Investor Concerns - TipRanks
Nevro Corp stock target cut, keeps underweight rating on Q3 results - Investing.com
Nevro wins CE mark for HFX iQ spinal cord stim for pain relief - Mass Device
Nevro price target raised to $6 from $5 at Baird - TipRanks
Nevro stock price target cut, retains underweight on earnings beat - Investing.com
Why Medical Device Firm Nevro Stock Is Trading Higher On TuesdayNevro (NYSE:NVRO) - Benzinga
Nevro (NYSE:NVRO) Price Target Cut to $7.00 by Analysts at Canaccord Genuity Group - MarketBeat
Nevro's (NVRO) "Sector Perform" Rating Reiterated at Royal Bank of Canada - MarketBeat
Peeling Back The Layers: Exploring Nevro Through Analyst Insights - Benzinga
Piper Sandler Cuts Nevro (NYSE:NVRO) Price Target to $6.00 - MarketBeat
Nevro Corp. (NYSE:NVRO) Q3 2024 Earnings Call Transcript - MSN
Nevro (NYSE:NVRO) Price Target Raised to $6.00 - MarketBeat
Nevro Corp stock target upgraded, neutral rating on margin outlook By Investing.com - Investing.com UK
Nevro Corp (NVRO) PT Lowered to $6 at Piper Sandler - StreetInsider.com
Nevro receives CE Mark Certification in Europe for HFX iQ SCS System - TipRanks
Nevro Corp (NVRO) PT Raised to $6 at Baird - StreetInsider.com
Nevro's HFX iQ™ Spinal Cord Stimulation with AI Technology Receives CE Mark Certification in Europe, Increasing Product Expansion Globally - PR Newswire
Nevro Corp (NVRO) PT Lowered to $7 at Canaccord Genuity - StreetInsider.com
Nevro price target lowered to $6 from $7 at Piper Sandler - TipRanks
Nevro Corp earnings beat by $0.40, revenue topped estimates - Investing.com Canada
Nevro stock price target cut, retains underweight on earnings beat By Investing.com - Investing.com UK
Nevro Corp. Shows Resilience Amidst Revenue Challenges - TipRanks
Nevro: Q3 Earnings Snapshot - CT Insider
Nevro Corp. Reports Earnings Results for the Third Quarter Ended September 30, 2024 - Marketscreener.com
0.65%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):